Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vifor Pharma
Pharma
With proposal, CSL Vifor attempts to avoid antitrust penalty
CSL Vifor has proposed to launch a campaign that would undo the potentially misleading messages it sent about the safety of a rival product.
Kevin Dunleavy
Apr 19, 2024 11:57am
CSL Vifor lays off 85 staffers in wake of $11.7B buyout
Sep 5, 2023 4:15pm
Record plasma collections spark a revenue boost for CSL
Aug 16, 2023 11:32am
Sarepta pawns off PRV for $102M to unidentified buyer
Jul 6, 2023 8:10am
Akebia proposes new dosing for oral anemia drug amid FDA dispute
Apr 3, 2023 11:34am
New CEO Paul McKenzie plots CSL's course for growth
Apr 3, 2023 9:25am